GetTopicDetailResponse(id=64e910548245, topicName=醛固酮合成酶抑制劑, introduction=醛固酮合成酶抑制劑, content=醛固酮合成酶抑制劑Baxdrostat的降壓療效, image=null, comments=1, allHits=1195, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=4754896, adminEncryptionId=f63e4754896, adminName=俠膽醫(yī)心, createdBy=f63e4754896, createdName=俠膽醫(yī)心, createdAvatar=, createdTime=Tue Mar 07 10:44:34 CST 2023, time=2023-03-07, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=472759, tagList=[TagDto(tagId=472759, tagName=醛固酮合成酶抑制劑)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2258416, encodeId=367c225841695, content=<a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血壓#</a> <a href='/topic/show?id=64e910548245' target=_blank style='color:#2F92EE;'>#醛固酮合成酶抑制劑#</a> <a href='/topic/show?id=8bef1255028b' target=_blank style='color:#2F92EE;'>#ACC 2025#</a>, objectTitle=抗醛固酮治療有望成為改善全球血壓控制的重要途徑！劉靖教授解讀lorundrostat降壓研究 | ACC.25, objectType=article, longId=869672, objectId=2ef68696e247, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250220/1740054122286_8538692.jpg, objectUrl=/article/show_article.do?id=2ef68696e247, replyNumber=0, likeNumber=48, createdTime=2025-03-30, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ef68696e247, moduleTitle=抗醛固酮治療有望成為改善全球血壓控制的重要途徑！劉靖教授解讀lorundrostat降壓研究 | ACC.25, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2ef68696e247)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2252097, encodeId=6da9225209e78, content=<a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血壓#</a> <a href='/topic/show?id=64e910548245' target=_blank style='color:#2F92EE;'>#醛固酮合成酶抑制劑#</a>, objectTitle=全球13億高血壓患者新希望？新研究：降壓潛在新選擇，值得臨床關(guān)注, objectType=article, longId=863426, objectId=d4b2863426e1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240515/1715776805991_5579292.jpg, objectUrl=/article/show_article.do?id=d4b2863426e1, replyNumber=0, likeNumber=40, createdTime=2025-02-15, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=d4b2863426e1, moduleTitle=全球13億高血壓患者新希望？新研究：降壓潛在新選擇，值得臨床關(guān)注, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d4b2863426e1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2250627, encodeId=e8fd225062e83, content=<a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血壓#</a> <a href='/topic/show?id=b1e545e085e' target=_blank style='color:#2F92EE;'>#安全性#</a> <a href='/topic/show?id=64e910548245' target=_blank style='color:#2F92EE;'>#醛固酮合成酶抑制劑#</a>, objectTitle=Hypertension：醛固酮合成酶抑制劑治療高血壓的療效和安全性, objectType=article, longId=862094, objectId=169086209472, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250205/1738726804954_8538692.jpg, objectUrl=/article/show_article.do?id=169086209472, replyNumber=0, likeNumber=37, createdTime=2025-02-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=湖南省, moduleDTOList=[ModuleDTO(moduleId=169086209472, moduleTitle=Hypertension：醛固酮合成酶抑制劑治療高血壓的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=169086209472)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2118078, encodeId=fd4021180e819, content=<a href='/topic/show?id=64e910548245' target=_blank style='color:#2F92EE;'>#醛固酮合成酶抑制劑#</a><a href='/topic/show?id=10991052e27e' target=_blank style='color:#2F92EE;'>#Baxdrostat#</a>的<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降壓#</a>療效, objectTitle=醛固酮合成酶抑制劑Baxdrostat的降壓療效仍需要進(jìn)一步研究, objectType=article, longId=761852, objectId=1c95e6185211, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230306/1678110527971_8252897.jpeg, objectUrl=/article/show_article.do?id=1c95e6185211, replyNumber=0, likeNumber=158, createdTime=2023-03-07, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1c95e6185211, moduleTitle=醛固酮合成酶抑制劑Baxdrostat的降壓療效仍需要進(jìn)一步研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1c95e6185211)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
俠膽醫(yī)心
2023-03-07發(fā)表于上海
